Extra-pulmonary tuberculosis: towards an integrated diagnostic and management pathway: a narrative review

Aarti Kotwal; Vikram Sethi; Minakshi Singh; Shailendra Raghuvanshi; Varuna Jethani; Smita Chandra

doi:10.18203/2320-6012.ijrms20264223

Authors

Aarti Kotwal Department of Microbiology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, India
Vikram Sethi Department of Microbiology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, India
Minakshi Singh Department of Microbiology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, India
Shailendra Raghuvanshi Department of Radio-diagnosis, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, India
Varuna Jethani Department of Respiratory Medicine, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, India
Smita Chandra Department of Pathology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Swami Ram Nagar, Jolly Grant, Dehradun, Uttarakhand, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20264223

Keywords:

Tuberculosis, Extrapulmonary tuberculosis, Diagnosis, Xpert MTB/RIF Ultra, Drug-resistant tuberculosis, Multidisciplinary management

Abstract

Extrapulmonary tuberculosis (EPTB) accounts for a substantial and increasing share of global tuberculosis (TB) notifications, yet remains disproportionately difficult to diagnose because of its paucibacillary nature, heterogeneous organ involvement, and the fragmented way in which clinical, radiological, histopathological, and microbiological data are typically interpreted. To synthesize current evidence on EPTB diagnosis and management within a single pathway-based framework, with attention to organ specific diagnostic yield, special populations, and unresolved controversies. This narrative review synthesizes evidence from World Health Organization (WHO) consolidated guidelines, Cochrane systematic reviews, landmark randomized trials and recent diagnostic accuracy studies to provide an updated overview of the diagnosis and management of EPTB. Evidence suggests that no single test reliably excludes EPTB, diagnostic yield varies markedly by disease site and specimen type, with Xpert MTB/RIF Ultra outperforming Xpert MTB/RIF and smear microscopy across most extrapulmonary specimens but still leaving important gaps, particularly in cerebrospinal and pleural fluid. Children and people living with HIV are disproportionately affected and pose distinct diagnostic challenges. Management increasingly requires site-specific tailoring, especially for drug-resistant disease, where current WHO shorter regimens explicitly exclude central nervous system, osteoarticular, and disseminated forms. An integrated, multidisciplinary diagnostic pathway rather than test by test or organ by organ, evaluation offers the most practical framework for reducing diagnostic delay in EPTB.

References

World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization; 2025. Available at: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025. Accessed 2 April 2026.

VidyaRaj CK, Vadakunnel MJ, Mani BR, Anbazhagi M, Pradhabane G, Venkateswari R, et al. Prevalence of extrapulmonary tuberculosis and factors influencing successful treatment outcomes among notified cases in South India. Sci Rep. 2025;15:8290.

Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015;78(2):47-55.

Tulu B, Brehm TT, van Crevel R, Dallenga T, DiNardo AR, Dheda K, et al. Host- and pathogen-related determinants of pulmonary versus extrapulmonary tuberculosis. Eur Respir Rev. 2026;35(179):250174.

Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Denkinger CM, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1(1):CD012768.

Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435-46.

Dang MT, Lukas K, Choi DH, Chu TJ, Venketaraman V. Diagnostic imaging of extrapulmonary tuberculosis across organ systems. Diagnostics (Basel). 2026;16(4):586.

Gopalaswamy R, Dusthackeer VNA, Kannayan S, Subbian S. Extrapulmonary tuberculosis—an update on the diagnosis, treatment and drug resistance. J Respir. 2021;1(2):141-64.

Lyu J, Narum DE, Baldwin SL, Larsen SE, Bai X, Griffith DE, et al. Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front Immunol. 2024;15:1427559.

Mali S, Beena PM, Arvind N. Evaluation of microscopy, culture and PCR assay in the diagnosis of extrapulmonary tuberculosis. J Pure Appl Microbiol. 2018;12(2):871-7.

Ministry of Health and Family Welfare, Government of India. Training module on extrapulmonary tuberculosis. New Delhi: Ministry of Health and Family Welfare; 2023. Available at: https://tbcindia.mohfw.gov.in/wp-content/uploads/2023/05/7702334778Training_Module_on_Extrapulmonary_TB_-_Book_24032023.pdf. Accessed 2 April 2026.

Carabalí-Isajar ML, Rodríguez-Bejarano OH, Amado T, Patarroyo MA, Izquierdo MA, Lutz JR, et al. Clinical manifestations and immune response to tuberculosis. World J Microbiol Biotechnol. 2023;39(8):206.

Goletti D, Pisapia R, Fusco FM, Aiello A, van Crevel R. Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes. Int J Tuberc Lung Dis. 2023;27(4):284-90.

Rabello E, de-Paris F. Tuberculosis diagnostic methods: clinical applicability, implementation challenges, and integrated testing strategies. Pathogens. 2026;15(2):142.

Almutairi M, Alalmaee R, Alamer E, Alharbi S, Aljarallah G, Almukhayzim R, et al. Diagnostic utility of Xpert MTB/RIF Ultra in clinically suspected tuberculous lymphadenitis in low-burden settings: a single-center experience from Saudi Arabia. J Clin Tuberc Other Mycobact Dis. 2026;43:100603.

World Health Organization. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis—rapid diagnostics for tuberculosis detection. 3rd ed. Geneva: World Health Organization; 2024. Available from: https://www.who.int/publications/i/item/9789240089488. Accessed 5 June 2026.

Shetty D, Vyas D. Combination method for the diagnosis of tuberculous lymphadenitis in high burden settings. Surg Exp Pathol. 2022;5:11.

Vorster MJ, Allwood BW, Diacon AH, Koegelenberg CF. Tuberculous pleural effusions: advances and controversies. J Thorac Dis. 2015;7(6):981-91.

Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008;102(5):744-54.

Bian Y, Deng M, Zhang Q, Hou G. Global trends of research on tuberculous pleurisy over the past 15 years: a bibliometric analysis. Front Cell Infect Microbiol. 2022;12:937811.

Pant A, Farrokhi F, Gyawali P, Yekuno K, Shah O, Singh S, et al. Global research trends in central nervous system tuberculosis—a bibliometric analysis. J Clin Tuberc Other Mycobact Dis. 2024;34:100414. doi:10.1016/j.jctube.2024.100414.

Marais S, Thwaites G, Schoeman JF, Torok ME, Misra UK, Prasad K, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803-12.

Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741-51.

Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608-16.

Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med. 2014;371(12):1121-30.

Sethi V, Raghuvanshi S, Kotwal A, Khanduri RS, Jethani V. Multidrug-resistant musculoskeletal tuberculosis: an aggressive clinical, radiological and molecular confirmation with genotypic drug susceptibility testing approach. Cureus. 2022;14(9):e28720.

Subramanian R, Prasad S, Mamadapur M. Musculoskeletal manifestations in tuberculosis. Best Pract Res Clin Rheumatol. 2025;39(2):102057.

Tseng C, Huang RM, Chen KT. Tuberculosis arthritis: epidemiology, diagnosis, treatment. Clin Res Foot Ankle. 2014;2:131.

Garg RK, Somvanshi DS. Spinal tuberculosis: a review. J Spinal Cord Med. 2011;34(5):440-54.

Jha DK, Pathiyil MM, Sharma V. Evidence-based approach to diagnosis and management of abdominal tuberculosis. Indian J Gastroenterol. 2023;42(1):17-31.

Gunasekaran J, Ranjan R, Karlapudi P, Pandey P, Chichhal K, Gupta S, et al. Prevalence of microbiologically confirmed female genital tuberculosis in a tertiary care hospital in Faridabad, Haryana, India. Cureus. 2024;16(12):e75358.

Kulchavenya E, Naber K, Bjerklund Johansen TE. Urogenital tuberculosis: classification, diagnosis, and treatment. Eur Urol Suppl. 2016;15(4):112-21.

Agrawal R, Testi I, Mahajan S, Yuen YS, Agarwal A, Kon OM, et al. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for initiating antitubercular therapy in tubercular choroiditis. Ophthalmology. 2021;128(2):266-76.

Miranda E, Widaty S, Sirait SP, Rizky LA, Menaldi SL, Lim HW. Correlation between clinical and histopathological findings of five puzzling cases of cutaneous tuberculosis. J Gen Proced Dermatol Venereol Indones. 2020;5(1):48-55.

Mashiach D, Shon J, Mashiach R, Ayzenberg G, Barazani O, Aabedi A, et al. Pediatric tuberculosis: unraveling immunity, clinical complexities, and resource-driven disparities in the pursuit of prevention. Vaccines (Basel). 2026;14(2):119.

Santiago-García B, Blázquez-Gamero D, Baquero-Artigao F, Ruíz-Contreras J, Bellón JM, Muñoz-Fernández MA, et al. Pediatric extrapulmonary tuberculosis: clinical spectrum, risk factors and diagnostic challenges in a low prevalence region. Pediatr Infect Dis J. 2016;35(11):1175-81.

Diedrich CR, O'Hern J, Wilkinson RJ. HIV-1 and the Mycobacterium tuberculosis granuloma: a systematic review and meta-analysis. Tuberculosis (Edinb). 2016;98:62-76.

Pongpirul W, Phutrakool P, Pongpirul K. Diagnostic modality influences tuberculosis detection in people living with HIV: eight years of data from a Thai referral center. Diagnostics (Basel). 2025;15(18):2327.

Chaudhari S, Batra N, Halwal D, Bhat S. FNAC of tubercular lymph node—an alternative to excision biopsy. Indian J Pathol Oncol. 2016;3(2):237-41.

Medical Research Council Working Party on Tuberculosis of the Spine. Five-year assessments of controlled trials of ambulatory treatment, debridement and anterior spinal fusion in the management of tuberculosis of the spine: studies in Bulawayo (Rhodesia) and in Hong Kong. Sixth report of the Medical Research Council Working Party on Tuberculosis of the Spine. J Bone Joint Surg Br. 1978;60-B(2):163-77.

Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, et al. Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India. Indian J Med Res. 2017;145(4):448-63.

Maleki Rad M, Haddad M, Sheybani F, Shirazinia M, Dadgarmoghaddam M. Mortality predictors and diagnostic challenges in adult tuberculous meningitis: a retrospective cohort of 100 patients. Trop Med Health. 2025;53(1):58.

Wang C, Fang L, Zhu W, Lin X, Guo X, Chen A, et al. Empirical anti-tuberculous therapy for the massive pericardial effusion of unknown etiology. Curr Med Res Opin. 2021;37(9):1507-13.

Li Y, Bian W, Wu S, Zhang J, Li D. Metagenomic next-generation sequencing for Mycobacterium tuberculosis complex detection: a meta-analysis. Front Public Health. 2023;11:1224993.

Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol. 2012;65(3):456-66.

Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, et al. Tuberculosis in Spain: an opinion paper. Rev Esp Quimioter. 2023;36(6):562-83.

World Health Organization. WHO consolidated guidelines on tuberculosis: Module 4: treatment and care [Internet]. Geneva: World Health Organization; 2025. Chapter 2, Drug-resistant TB treatment. Available from: https://www.ncbi.nlm.nih.gov/books/NBK613101/. Accessed 12 April 2026.

Boonsarngsuk V, Mangkang K, Santanirand P. Prevalence and risk factors of drug-resistant extrapulmonary tuberculosis. Clin Respir J. 2018;12(6):2101-9.

Diriba G, Tola HH, Alemu A, Yenew B, Gamtesa DF, Kebede A. Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: a systematic review and meta-analysis. PLoS One. 2021;16(10).

Sethi V, Kotwal A, Jethani V, Pathe C, Maurya AK. Burden and trend of drug resistant tuberculosis: is the onus on isoniazid monoresistant TB now? Indian J Tuberc. 2026;73(2):182-5.

World Health Organization. WHO consolidated guidelines on tuberculosis: Module 4: treatment—drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022. Available at: https://www.who.int/publications/i/item/9789240063129. Accessed 11 April 2026.

Jørstad MD, Dyrhol-Riise AM, Aßmus J, Marijani M, Sviland L, Mustafa T. Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting. BMC Infect Dis. 2019;19:426.

Leowattana W, Leowattana P, Leowattana T. Tuberculosis of the spine. World J Orthop. 2023;14(5):275-93.

Velicheti S, Hanumanthu M, Godaba PP, Vanjavakam S, Madala PV, Sadineni R. Imaging in spinal tuberculosis: a comprehensive radiologic review. Indian J Musculoskelet Radiol. 2026;8:43-58.

Pedroso A, Ferreira I, Chikura T. Tuberculosis and sarcoidosis overlap: a clinical challenge from diagnosis to treatment. Cureus. 2020;12(11).

Ekeng BE, Davies AA, Osaigbovo II, Warris A, Oladele RO, Denning DW. Pulmonary and extrapulmonary manifestations of fungal infections misdiagnosed as tuberculosis: the need for prompt diagnosis and management. J Fungi (Basel). 2022;8(5):460.

World Health Organization. WHO consolidated guidelines on tuberculosis: Module 3: diagnosis. Geneva: World Health Organization; 2025. Available at: https://www.ncbi.nlm.nih.gov/books/NBK614638/. Accessed 20 April 2026.

Aggarwal AN, Agarwal R, Sehgal IS, Dhooria S. Adenosine deaminase for diagnosis of tuberculous pleural effusion: a systematic review and meta-analysis. PLoS One. 2019;14(3).

Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: a systematic review and comparative meta-analysis. PLoS One. 2022;17(7).

Rahman SMM, Nasrin R, Kabir S, Kabir F, Rahman AMR, Uddin MKM, et al. Performance of Xpert MTB/RIF Ultra for the diagnosis of tuberculous meningitis in children using cerebrospinal fluid. Sci Rep. 2025;15(1):13060.

Yayan J, Franke KJ, Berger M, Windisch W, Rasche K. Early detection of tuberculosis: a systematic review. Pneumonia (Nathan). 2024;16(1):11.

Schwab TC, Perrig L, Göller PC, Guebely De la Hoz FF, Lahousse AP, Minder B, et al. Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2024;24(10):1162-76.

Elbehiry A, Abalkhail A. Metagenomic next-generation sequencing in infectious diseases: clinical applications, translational challenges, and future directions. Diagnostics (Basel). 2025;15(16):1991.

Chen P, Sun W, He Y. Comparison of metagenomic next-generation sequencing technology, culture and GeneXpert MTB/RIF assay in the diagnosis of tuberculosis. J Thorac Dis. 2020;12(8):4014-24.

Cui Y, Li H, Liu T, Zhong R, Guo J, Du J, et al. The evolving landscape of host biomarkers for diagnosis and monitoring of tuberculosis. Biomedicines. 2025;13(9):2076.

Matuku-Kisaumbi P. The role of TB biomarkers in diagnosis, prognosis and prevention of tuberculosis. In: de Mesquita JB, editor. Improving societal systems to end tuberculosis. London: IntechOpen; 2024.

Kardjadj M. Advances in point-of-care infectious disease diagnostics: integration of technologies, validation, artificial intelligence, and regulatory oversight. Diagnostics (Basel). 2025;15(22):2845.

Ninan MM, Rupali P, Varghese GM, Shalini EB, Venkatesh K, Jesudason MR, et al. Xpert Ultra in diagnosing extrapulmonary TB: accuracy and trace calls. Int J Tuberc Lung Dis 2022; 26(5):435-42.

Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis 2018; 18(1):68-75.

Antel K, Oosthuizen J, Malherbe F, Louw VJ, Nicol MP, Maartens G, et al. Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis. BMC Infect Dis. 2020; 20(1):33.